Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors

Table 1

Clinical features of patients.

Patient	Gender	Age at diagnosis	Tumor site	NF status	Initial path	Grade	Cycles of; chemo	Decrease in tumor (%)	Final path	Clinical status	Overall; survival; (months)
Patient 1	M	59	Axilla	Yes	Neuroepithelial differentiation of MPNST	Unable to review	5	47	Residual fibroadipose tissue and metastatic sarcoma in 3/12 lymph nodes	NED	36
Patient 2	M	27	Mediastinum	Yes	MPNST	FNCLCC Grade 2	11	39	MPNST and areas of lung with pneumocyte hyperplasia	Deceased	14
Patient 3	M	29	RP	No	MPNST	FNCLCC Grade 3	6	15	MPNST with 80% treatment effect	NED	42
Patient 4	F	54	Brachial plexus	No	MPNST	FNCLCC Grade 2	5	33	CR without surgery	NED	43
Patient 5	M	35	Neck	Yes	MPNST	FNCLCC; Grade 3	5	0	MPNST with 20% treatment effect	NED	9

RP = retroperitoneum.